Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction - Concepedia

Concepedia

Publication | Open Access

Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction

DOI Full Paper Access

205

Citations

15

References

2013

Year

Jean‐Claude Tardif, Jean-François Tanguay, Scott Wright, Valérie Duchatelle, Thibaut Petroni, Jean C. Grégoire, Réda Ibrahim, Therèse Heinonen, Stephen Robb, Olivier F. Bertrand,

Journal of the American College of Cardiology

Abstract

Inclacumab appears to reduce myocardial damage after PCI in patients with non-ST-segment elevation myocardial infarction. (A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction [Non-STEMI] Undergoing Percutaneous Coronary Intervention; NCT01327183).

References

	Year	Citations

Page 1